Protein Misfolding, Functional Amyloid, and Human Disease
Top Cited Papers
- 1 June 2006
- journal article
- review article
- Published by Annual Reviews in Annual Review of Biochemistry
- Vol. 75 (1) , 333-366
- https://doi.org/10.1146/annurev.biochem.75.101304.123901
Abstract
Peptides or proteins convert under some conditions from their soluble forms into highly ordered fibrillar aggregates. Such transitions can give rise to pathological conditions ranging from neurodegenerative disorders to systemic amyloidoses. In this review, we identify the diseases known to be associated with formation of fibrillar aggregates and the specific peptides and proteins involved in each case. We describe, in addition, that living organisms can take advantage of the inherent ability of proteins to form such structures to generate novel and diverse biological functions. We review recent advances toward the elucidation of the structures of amyloid fibrils and the mechanisms of their formation at a molecular level. Finally, we discuss the relative importance of the common main-chain and side-chain interactions in determining the propensities of proteins to aggregate and describe some of the evidence that the oligomeric fibril precursors are the primary origins of pathological behavior.Keywords
This publication has 193 references indexed in Scilit:
- The most infectious prion protein particlesNature, 2005
- Correlation of structural elements and infectivity of the HET-s prionNature, 2005
- Structure of the cross-β spine of amyloid-like fibrilsNature, 2005
- Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 2004
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Rationalization of the effects of mutations on peptide andprotein aggregation ratesNature, 2003
- Functional profiling of the Saccharomyces cerevisiae genomeNature, 2002
- Therapeutic strategies for human amyloid diseasesNature Reviews Drug Discovery, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002